Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,818 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02519712 | Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors | terminated | N/A | 4 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 6, 2018 | clinicaltrials |
| NCT01757717 | Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis | completed | N/A | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 |
| Mar 20, 2018 |
| clinicaltrials |
| NCT01259063 | RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder | completed | Phase 1 / Phase 2 | 33 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 13, 2018 | clinicaltrials |
| NCT00200161 | Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma | completed | Phase 2 | 127 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 7, 2018 | clinicaltrials |
| NCT00483678 | Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners | completed | N/A | 64 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 6, 2018 | clinicaltrials |
| NCT00601185 | Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo. | completed | — | 116 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 27, 2018 | clinicaltrials |
| NCT00587093 | A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer | completed | N/A | 669 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 22, 2018 | clinicaltrials |
| NCT00588263 | Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer | withdrawn | — | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 19, 2018 | clinicaltrials |
| NCT01803516 | QOL Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye Laser | completed | — | 22 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 7, 2018 | clinicaltrials |
| NCT00782756 | Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma | completed | Phase 2 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 6, 2018 | clinicaltrials |
| NCT01213004 | Evaluation of Respiratory Motion-Corrected Cone-Beam CT in Radiation Treatment of Thoracic and Abdominal Cancers | completed | N/A | 52 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 6, 2018 | clinicaltrials |
| NCT02163187 | Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation | terminated | Phase 2 / Phase 3 | 4 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT00661427 | Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer | completed | Phase 2 | 61 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 11, 2018 | clinicaltrials |
| NCT01418001 | Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) | terminated | Phase 1 / Phase 2 | 5 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 11, 2018 | clinicaltrials |
| NCT00577707 | Erlotinib and Chemotherapy for Patients With Stage IB-IIIA NSCLC With EGFR Mutations (ECON) | completed | Phase 2 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 10, 2018 | clinicaltrials |
| NCT00052429 | High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer | completed | Phase 1 / Phase 2 | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT00667615 | Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) | completed | Phase 1 / Phase 2 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 5, 2018 | clinicaltrials |
| NCT02628912 | Cardiopulmonary Fitness in Long-Term Survivors of HPV-related Oropharynx Cancers | withdrawn | — | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 0 | Jan 4, 2018 | clinicaltrials |
| NCT01992471 | Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After Testing | completed | — | 197 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 5, 2017 | clinicaltrials |
| NCT00470366 | Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors | completed | Phase 2 | 60 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 28, 2017 | clinicaltrials |
| NCT01558661 | Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma | completed | Phase 2 | 33 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 28, 2017 | clinicaltrials |
| NCT01386411 | Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer | completed | — | 108 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 8, 2017 | clinicaltrials |
| NCT01209598 | PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma | completed | Phase 2 | 90 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT01826227 | Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer | completed | N/A | 5 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT00425802 | Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia | completed | Phase 2 | 61 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT01721525 | Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC) | completed | Phase 1 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 25, 2017 | clinicaltrials |
| NCT00003659 | Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia | completed | Phase 2 | 39 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 24, 2017 | clinicaltrials |
| NCT00142506 | Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer | completed | Phase 3 | 290 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 20, 2017 | clinicaltrials |
| NCT00573833 | Internal Radiation Therapy in Treating Patients With Prostate Cancer | completed | N/A | 23 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 20, 2017 | clinicaltrials |
| NCT00578032 | Reconstructive Surgery For Head And Neck Cancer Patients | completed | — | 80 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 19, 2017 | clinicaltrials |
| NCT02301364 | Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL) | completed | Phase 2 | 4 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 19, 2017 | clinicaltrials |
| NCT01596283 | Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection | completed | Phase 3 | 135 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 18, 2017 | clinicaltrials |
| NCT02241187 | Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection | completed | N/A | 2 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 27, 2017 | clinicaltrials |
| NCT01864083 | FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients | completed | Early Phase 1 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 31, 2017 | clinicaltrials |
| NCT01866293 | Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma | completed | Phase 1 / Phase 2 | 11 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 30, 2017 | clinicaltrials |
| NCT01622660 | Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy | terminated | Phase 2 | 2 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT00423930 | Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | 44 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 18, 2017 | clinicaltrials |
| NCT01579929 | Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) | completed | Phase 1 | 19 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 17, 2017 | clinicaltrials |
| NCT00721630 | Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer | completed | Phase 2 | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 15, 2017 | clinicaltrials |
| NCT00541034 | Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia | completed | Phase 2 | 49 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 11, 2017 | clinicaltrials |
| NCT00776867 | Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors | completed | Phase 1 | 38 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT01252251 | RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma | completed | Phase 2 | 14 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT00579618 | Ascertainment of Saliva or Blood Samples For Genetic Epidemiology Studies of Cancer and Aging | completed | — | 53 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 31, 2017 | clinicaltrials |
| NCT01084642 | Female Cancer Patients' Preference For Sexual Health Interventions | completed | — | 229 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 6, 2017 | clinicaltrials |
| NCT02836535 | The Patient-Perspective of Complications After Colon and Rectum Surgery: A Qualitative Analysis | completed | — | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 29, 2017 | clinicaltrials |
| NCT01830582 | Advanced MR Imaging for Early Biologic Tumor Changes to Neoadjuvant Chemoradiation Treatment for Rectal Cancer | completed | N/A | 28 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 22, 2017 | clinicaltrials |
| NCT01392222 | Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others | completed | — | 21 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2017 | clinicaltrials |
| NCT02647190 | Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older | withdrawn | Phase 1 | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 2, 2017 | clinicaltrials |
| NCT00595322 | Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma | completed | N/A | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 23, 2017 | clinicaltrials |
| NCT01436240 | Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) | completed | — | 112 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 23, 2017 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials